Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical BusinessBusiness Wire • 11/22/22
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/03/22
Are Medical Stocks Lagging Aerie Pharmaceuticals (AERI) This Year?Zacks Investment Research • 10/17/22
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERIBusiness Wire • 10/14/22
Is Aerie Pharmaceuticals (AERI) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 09/29/22
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This YearInvestors Business Daily • 09/19/22
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment OptionsBusiness Wire • 09/13/22
Is Aerie Pharmaceuticals (AERI) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 09/12/22
Has Aerie Pharmaceuticals (AERI) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 08/26/22
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ONEM, CCXI, AERI, SFTPRNewsWire • 08/25/22
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Aerie Pharmaceuticals, Inc. BuyoutNewsfile Corp • 08/24/22
AERI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Aerie Pharmaceuticals, Inc. Is Fair to ShareholdersBusiness Wire • 08/24/22
Shareholder Alert: Ademi LLP investigates whether Aerie Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with AlconPRNewsWire • 08/23/22
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical PortfolioBusiness Wire • 08/23/22